Oxygent perflubron: Began Phase III study

Alliance Pharmaceutical Corp. (ALLP), San Diego, Calif.
Product: Oxygent perflubron
Business: Blood products/substitutes
Therapeutic category: Blood substitute
Target: N/A
Description: Intravenous

Read the full 211 word article

How to gain access

Continue reading with a
two-week free trial.